Search
- Dec 5, 2023
Marianne De Backer talks about joining Vir Biotechnology and shares her vision for the future
Vir's new CEO gives an overview of the company's programs and discusses future plans to expand into autoimmune disease and oncology.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A